BIOLASE, Inc.

About BIOLASE, Inc.

BIOLASE is a global leader in dental lasers, providing state-of-the-art technology that delivers precision, efficiency, and patient comfort through minimally invasive solutions. Their mission is to advance laser dentistry and empower dental practices with innovative solutions.

Products & Services

Waterlase iPlus Premier Edition™:Flagship all-tissue dental laser with new updates, designed for a wide range of dental procedures.

Waterlase iPlus:Recognized as the #1 all-tissue dental laser, used for various dental applications.

Waterlase MDX:An all-tissue laser for dental procedures.

Waterlase Fractional Handpiece™:A specialized handpiece for use with Waterlase lasers.

Epic X™:A soft-tissue laser offering a total diode solution for dental practices.

Epic Hygiene™:A soft-tissue laser designed specifically for hygienists.

Specialties

Dental Lasers All-Tissue Lasers Soft-Tissue Lasers Laser Dentistry Education Minimally Invasive Dental Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 7000000 MR: - FA: approximately $7.0 million FAN: 7000000	D: 2024-02-15 FD: 2024-02-15	-
2	RT: Public Offering T: - FT: Public Offering	A: 7000000 MR: - FA: 7.0 million FAN: 7000000	D: 2024-02-13 FD: 2024-02-13	-
3	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 1400000 MR: - FA: 1.4 million FAN: 1400000	D: 2023-12-06 FD: 2023-12-06	1 investors
4	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 4500000 MR: - FA: 4.5 million FAN: 4500000	D: 2023-05-26 FD: 2023-05-26	2 investors
5	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 4500000 MR: - FA: $4.5 million FAN: 4500000	D: 2023-05-24 FD: 2023-05-24	2 investors
6	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 9750000 MR: - FA: approximately $9.75 million FAN: 9750000	D: 2023-01-10 FD: 2023-01-10	2 investors

Public Offering Latest

2024-02-15

$7.0M

Public Offering 2024-02-13

$7.0M

Registered Direct Offering 2023-12-06

$1.4M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Steven Gordon

Marketing

D

Dr. Kwang Bum Park

CEO of MegaGen & BIOLASE

Recent News

BIOLASE, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised